Exploring Zanidatamab's efficacy across HER2-positive Malignancies: a narrative review. Kanwal W, Narjis K, Musani S, Nancy F, et al. BMC Cancer 2025;25:382.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kanwal W, Narjis K, Musani S, Nancy F, et al. Exploring Zanidatamab's efficacy across HER2-positive Malignancies: a narrative review. BMC Cancer 2025;25:382.
PMID: 40025472